Solabegron Hydrochloride

N/A

Report date: 2024/05/02 20:00:03
NME

Base Information

Drug NameSolabegron Hydrochloride
Drug Alias Name索拉贝隆Solabegronum索拉勃隆GW-427353BGW-427353 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsUrinary Bladder, OveractiveIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanPoland +[15] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltherxGlaxosmithkline PlcVelicept Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG